Header Logo

elliot Servais

Concepts (236)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Robotic Surgical Procedures
11
2024
111
6.230
Why?
Lung Neoplasms
17
2024
589
5.000
Why?
Thoracic Surgery
6
2024
68
3.280
Why?
Esophageal Neoplasms
5
2024
79
2.710
Why?
Thoracic Surgical Procedures
5
2024
33
2.610
Why?
Surgeons
4
2023
159
2.170
Why?
Thoracic Surgery, Video-Assisted
6
2024
56
1.980
Why?
Pneumonectomy
6
2024
96
1.640
Why?
Esophagectomy
4
2024
47
1.480
Why?
Carcinoma, Non-Small-Cell Lung
5
2024
150
1.300
Why?
Early Detection of Cancer
2
2023
267
1.290
Why?
Databases, Factual
8
2024
813
1.170
Why?
Thoracic Wall
2
2023
18
1.010
Why?
Pleural Neoplasms
4
2014
19
0.980
Why?
Mesothelioma
4
2014
27
0.970
Why?
Anastomotic Leak
2
2023
33
0.940
Why?
Suture Techniques
1
2024
89
0.890
Why?
Esophageal Achalasia
1
2023
29
0.820
Why?
Natural Orifice Endoscopic Surgery
1
2023
36
0.820
Why?
Tracheoesophageal Fistula
1
2022
4
0.800
Why?
Humans
47
2024
60012
0.790
Why?
Herpes Simplex
1
2022
48
0.760
Why?
GPI-Linked Proteins
5
2014
37
0.730
Why?
Molecular Imaging
2
2011
46
0.710
Why?
Clinical Competence
2
2024
698
0.700
Why?
Unnecessary Procedures
1
2020
43
0.690
Why?
Radiation Dosage
1
2020
133
0.650
Why?
Tomography, X-Ray Computed
5
2020
1533
0.610
Why?
Retrospective Studies
15
2024
6140
0.610
Why?
Biomedical Research
1
2021
252
0.610
Why?
Societies, Medical
4
2024
344
0.570
Why?
Metastasectomy
1
2016
4
0.520
Why?
Treatment Outcome
9
2024
5305
0.500
Why?
Stomach
2
2012
85
0.470
Why?
Dyspnea
2
2012
119
0.470
Why?
Disease Models, Animal
2
2012
2061
0.460
Why?
Biomarkers, Tumor
3
2013
468
0.460
Why?
Disease Management
1
2016
225
0.440
Why?
Anastomosis, Surgical
2
2024
104
0.440
Why?
Neoplasm Staging
7
2024
458
0.440
Why?
Postoperative Complications
3
2021
1192
0.420
Why?
Tumor Burden
2
2021
61
0.420
Why?
Lymph Nodes
2
2011
217
0.420
Why?
Minimally Invasive Surgical Procedures
2
2024
93
0.410
Why?
Diaphragmatic Eventration
1
2012
2
0.400
Why?
Hernia, Diaphragmatic
1
2012
3
0.400
Why?
Pneumopericardium
1
2012
3
0.400
Why?
Gastric Fistula
1
2012
4
0.400
Why?
Puerperal Disorders
1
2012
14
0.400
Why?
Epithelioid Cells
1
2012
4
0.390
Why?
Pericardium
1
2012
35
0.390
Why?
Xenograft Model Antitumor Assays
2
2014
184
0.390
Why?
Lymphatic Metastasis
2
2011
72
0.380
Why?
Matrix Metalloproteinase 9
1
2012
59
0.380
Why?
Lung
4
2021
916
0.380
Why?
Thoracotomy
3
2021
46
0.360
Why?
Cesarean Section
1
2012
98
0.360
Why?
Models, Animal
1
2011
223
0.360
Why?
Neoplasm Metastasis
1
2011
198
0.360
Why?
Surgical Flaps
1
2012
112
0.360
Why?
Monitoring, Intraoperative
1
2010
47
0.350
Why?
Oximetry
1
2010
50
0.350
Why?
Digestive System Surgical Procedures
1
2010
88
0.330
Why?
Adenocarcinoma
3
2022
330
0.330
Why?
Pneumothorax
2
2024
49
0.320
Why?
Research Support as Topic
1
2009
42
0.310
Why?
Esophagus
2
2023
53
0.310
Why?
Female
19
2024
31036
0.310
Why?
Health Care Reform
1
2009
87
0.310
Why?
Bronchogenic Cyst
1
2008
2
0.300
Why?
Science
1
2009
34
0.300
Why?
Carcinoid Tumor
1
2008
13
0.300
Why?
Mediastinal Neoplasms
1
2008
17
0.300
Why?
Pancreatic Neoplasms
2
2010
333
0.300
Why?
Insurance, Health
1
2009
142
0.300
Why?
Epidermal Cyst
1
2008
10
0.300
Why?
Neoplasms, Second Primary
1
2008
42
0.290
Why?
Splenic Diseases
1
2008
16
0.290
Why?
Choristoma
1
2008
23
0.290
Why?
Pancreatic Diseases
1
2008
40
0.290
Why?
Middle Aged
14
2024
16449
0.280
Why?
Aged
13
2024
13497
0.280
Why?
Cell Transformation, Neoplastic
1
2008
196
0.270
Why?
Quality Improvement
2
2022
430
0.270
Why?
Spleen
1
2008
483
0.260
Why?
Decision Making, Computer-Assisted
1
2006
12
0.260
Why?
Antineoplastic Agents
1
2011
647
0.250
Why?
Prognosis
6
2022
1616
0.250
Why?
Computer-Assisted Instruction
1
2006
77
0.240
Why?
Urinary Bladder
1
2024
37
0.230
Why?
Education, Medical, Undergraduate
1
2006
152
0.230
Why?
Male
14
2024
27985
0.230
Why?
Aorta
1
2024
107
0.220
Why?
Animals
9
2024
19768
0.220
Why?
Swine
1
2024
351
0.220
Why?
Diagnosis, Differential
4
2012
940
0.220
Why?
Consensus
1
2024
202
0.220
Why?
Esophageal Sphincter, Lower
1
2023
20
0.210
Why?
Curriculum
2
2024
570
0.210
Why?
General Surgery
1
2006
193
0.210
Why?
Time Factors
3
2024
3630
0.210
Why?
Neoplasm Invasiveness
4
2022
248
0.210
Why?
Benchmarking
2
2023
138
0.210
Why?
Breast Neoplasms
1
2011
1122
0.200
Why?
Endoscopy
1
2023
104
0.200
Why?
Bronchoscopes
1
2022
10
0.200
Why?
Endoscopy, Gastrointestinal
1
2023
117
0.200
Why?
Simplexvirus
1
2022
25
0.200
Why?
Virtual Reality
1
2022
12
0.190
Why?
Education, Medical, Graduate
1
2024
317
0.190
Why?
Bronchoscopy
1
2022
83
0.190
Why?
Adult
11
2024
15862
0.190
Why?
Learning
1
2023
169
0.190
Why?
Adenocarcinoma in Situ
1
2021
3
0.190
Why?
Carbon Monoxide
1
2021
61
0.180
Why?
Robotics
1
2022
54
0.180
Why?
Simulation Training
1
2022
61
0.180
Why?
Carcinoma, Squamous Cell
1
2022
240
0.180
Why?
Data Warehousing
1
2020
8
0.180
Why?
Medicare
1
2024
600
0.170
Why?
Healthcare Disparities
1
2023
329
0.170
Why?
United States
5
2024
7504
0.170
Why?
Diagnostic Errors
1
2020
97
0.160
Why?
Neoplasm Recurrence, Local
3
2022
301
0.160
Why?
Predictive Value of Tests
2
2020
1037
0.160
Why?
Program Evaluation
1
2020
482
0.150
Why?
Colorectal Neoplasms
2
2012
266
0.140
Why?
Reproducibility of Results
2
2020
1582
0.140
Why?
Diagnostic Imaging
2
2011
245
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2012
409
0.140
Why?
Internship and Residency
1
2024
746
0.140
Why?
Follow-Up Studies
4
2024
2349
0.140
Why?
Recurrence
2
2024
604
0.140
Why?
Immunoenzyme Techniques
2
2012
107
0.120
Why?
Mice
4
2013
10344
0.120
Why?
Gallbladder Diseases
1
2015
26
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
2014
35
0.120
Why?
Cholecystectomy, Laparoscopic
1
2015
46
0.120
Why?
Patient Selection
2
2015
463
0.120
Why?
Drainage
2
2012
148
0.110
Why?
Cell Proliferation
3
2014
953
0.110
Why?
Immunotherapy, Adoptive
1
2014
87
0.110
Why?
Aged, 80 and over
5
2024
5159
0.110
Why?
Cell Movement
2
2013
431
0.110
Why?
Receptors, Antigen, T-Cell
1
2014
282
0.100
Why?
Rupture, Spontaneous
1
2012
22
0.100
Why?
Esophageal Atresia
1
2012
10
0.100
Why?
Sternotomy
1
2012
12
0.100
Why?
Laparotomy
1
2012
46
0.100
Why?
Methods
1
2011
41
0.100
Why?
Barrett Esophagus
1
2012
33
0.100
Why?
Osteopontin
1
2011
22
0.100
Why?
Cell Adhesion
1
2012
207
0.090
Why?
Oncolytic Viruses
1
2011
7
0.090
Why?
Chest Pain
1
2012
84
0.090
Why?
Real-Time Polymerase Chain Reaction
1
2012
193
0.090
Why?
Pleural Effusion, Malignant
1
2011
10
0.090
Why?
Luminescent Measurements
1
2011
39
0.090
Why?
Pleurodesis
1
2011
9
0.090
Why?
Chest Tubes
1
2011
15
0.090
Why?
Reoperation
1
2012
270
0.090
Why?
Sus scrofa
1
2010
27
0.090
Why?
Young Adult
3
2024
4330
0.090
Why?
Cell Hypoxia
1
2010
42
0.090
Why?
Catheters, Indwelling
1
2011
70
0.090
Why?
Oligonucleotide Array Sequence Analysis
1
2012
297
0.090
Why?
Blotting, Western
1
2012
594
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
534
0.090
Why?
CD4-Positive T-Lymphocytes
1
2014
625
0.090
Why?
Palliative Care
2
2011
218
0.090
Why?
Acute Disease
1
2012
669
0.090
Why?
Solitary Fibrous Tumor, Pleural
1
2010
1
0.090
Why?
Flow Cytometry
1
2012
641
0.090
Why?
Mice, Inbred BALB C
1
2012
874
0.080
Why?
Intestines
1
2010
158
0.080
Why?
Liver Neoplasms
1
2012
278
0.080
Why?
Politics
1
2009
32
0.080
Why?
Rats, Sprague-Dawley
1
2010
581
0.080
Why?
India
1
2009
155
0.080
Why?
Gene Expression Profiling
1
2012
721
0.080
Why?
Thigh
1
2008
25
0.080
Why?
Kidney
1
2010
415
0.070
Why?
Genetic Therapy
1
2014
735
0.070
Why?
Positron-Emission Tomography
1
2009
205
0.070
Why?
Biopsy, Fine-Needle
1
2008
63
0.070
Why?
Carcinoma, Basal Cell
1
2008
62
0.070
Why?
Survival Rate
2
2024
804
0.070
Why?
Rats
1
2010
1921
0.070
Why?
Length of Stay
2
2024
786
0.070
Why?
Apoptosis
1
2012
1045
0.070
Why?
RNA, Messenger
1
2012
1474
0.070
Why?
Risk Assessment
1
2012
1923
0.060
Why?
Pleura
1
2024
13
0.060
Why?
Emergency Service, Hospital
1
2012
1036
0.060
Why?
Mice, SCID
2
2014
514
0.050
Why?
Mice, Inbred NOD
2
2014
518
0.050
Why?
Suction
1
2022
34
0.050
Why?
Kaplan-Meier Estimate
2
2013
393
0.050
Why?
Neoplasm Grading
1
2021
77
0.050
Why?
Neoplasms
1
2011
1260
0.040
Why?
Longitudinal Studies
1
2024
1194
0.040
Why?
Cost-Benefit Analysis
1
2022
307
0.040
Why?
Water
1
2022
301
0.040
Why?
Cell Line, Tumor
2
2014
1395
0.040
Why?
Mitosis
1
2021
210
0.040
Why?
Computer Simulation
1
2022
463
0.040
Why?
Prospective Studies
2
2015
3089
0.030
Why?
Conversion to Open Surgery
1
2015
7
0.030
Why?
Chimerism
1
2014
11
0.030
Why?
Operative Time
1
2015
74
0.030
Why?
Cytotoxicity, Immunologic
1
2014
145
0.030
Why?
Neoplasm Transplantation
1
2013
162
0.030
Why?
Disease-Free Survival
1
2013
234
0.030
Why?
Transduction, Genetic
1
2014
230
0.030
Why?
HEK293 Cells
1
2014
590
0.020
Why?
Organoplatinum Compounds
1
2012
17
0.020
Why?
Mucins
1
2012
25
0.020
Why?
Camptothecin
1
2012
23
0.020
Why?
Lymphocyte Activation
1
2014
747
0.020
Why?
Chemotherapy, Adjuvant
1
2012
77
0.020
Why?
Single-Blind Method
1
2012
138
0.020
Why?
Hepatectomy
1
2012
60
0.020
Why?
Fibrosis
1
2012
154
0.020
Why?
Necrosis
1
2012
142
0.020
Why?
Preoperative Care
1
2012
180
0.020
Why?
Body Mass Index
1
2015
837
0.020
Why?
Gene Expression
1
2013
816
0.020
Why?
Multivariate Analysis
1
2012
915
0.020
Why?
Pancreaticoduodenectomy
1
2010
62
0.020
Why?
Cell Differentiation
1
2014
1312
0.020
Why?
Case-Control Studies
1
2012
1072
0.020
Why?
Pilot Projects
1
2012
926
0.020
Why?
Survival Analysis
1
2009
563
0.020
Why?
Disease Progression
1
2012
1127
0.020
Why?
Cohort Studies
1
2009
2406
0.010
Why?
Risk Factors
1
2012
5010
0.010
Why?
Servais's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (236)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_